Comprehensive tumour-immune profiling reveals TREM2⁺ tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma

Abstract

Background: Lymph node (LN) metastasis is a well-established independent prognostic factor in head and neck squamous cell carcinoma (HNSCC). Formation of suppressive tumour immune microenvironment (TIME) is a major contributor to tumour immune evasion and metastasis. However, the TIME landscape underlying LN-metastatic HNSCC remains poorly elucidated.

Methods: A total of 688 866 single-cell transcriptomes across 212 HNSCC samples were integrated. Comprehensive bioinformatic analyses on single-cell RNA sequencing and microarray datasets revealed a TREM2⁺ tumour-associated macrophage (TAM) cluster associated with LN metastasis. The functional role of TREM2⁺ TAMs was investigated through multiplex immunohistochemistry (mIHC) staining in clinical HNSCC cohort and in vitro co-culture experiments. Furthermore, machine learning algorithms were employed to construct a prognostic model for HNSCC.

Results: Integrative single-cell analysis revealed the immunosuppressive TIME of LN-metastatic HNSCC, characterised by high infiltration of exhausted CD8⁺ T cells (CD8⁺ Tex). We identified a specific TREM2⁺ TAM cluster that was strongly associated with CD8⁺ Tex infiltration and LN metastasis. In vitro experiment confirmed that TREM2⁺ TAMs promoted CD8⁺ T cell exhaustion. Mechanistically, TREM2⁺ TAMs exhibited a terminally differentiated phenotype driven by ETV5, and secreted SPP1 to interact with CD44 on CD8⁺ T cells, thus upregulating BHLHE40 to promote CD8⁺ Tex formation. Clinically, a prognostic model based on TREM2⁺ TAM signature genes was trained to independently predict HNSCC outcomes.

Conclusions: This study delineates the mechanism that TREM2⁺ TAMs promote LN metastasis in HNSCC by facilitating CD8⁺ T cells exhaustion via SPP1–CD44–BHLHE40 axis, proposing TREM2⁺ TAMs as potential therapeutic target for HNSCC.

Keywords

CD8⁺ Tex / HNSCC / LN metastasis / scRNA-seq / TIME / TREM2⁺ TAMs

References

[1] Qin H, Xu J, Yue Y, et al. Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC. Front Immunol. 2024; 15:1456649.

[2] Fan T, Wang X, Zhang S, et al. NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy. Signal Transduct Target Ther. 2022; 7(1): 130.

[3] Abou-Foul AK, Henson C, Chernock RD, et al. Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: head and neck cancer international group consensus recommendations. Lancet Oncol. 2024; 25(7): e286-e296.

[4] Chow LQM. Head and neck cancer. N Engl J Med. 2020; 382(1): 60-72.

[5] Lan T, Kuang S, Liang P, et al. MRI-based deep learning and radiomics for prediction of occult cervical lymph node metastasis and prognosis in early-stage oral and oropharyngeal squamous cell carcinoma: a diagnostic study. Int J Surg. 2024; 110(8): 4648-4659.

[6] Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020; 6(1): 92.

[7] Yu D, Pan M, Li Y, et al. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. J Exp Clin Cancer Res. 2022; 41(1): 6.

[8] Wen J, Wei Y, Jabbour SK, et al. Comprehensive analysis of prognostic value of lymph node staging classifications in patients with head and neck squamous cell carcinoma after cervical lymph node dissection. Eur J Surg Oncol. 2021; 47(7): 1710-1717.

[9] Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity. 2023; 56(10): 2188-2205.

[10] Xia X, Yang Z, Lu Q, et al. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy. Mol Cancer. 2024; 23(1): 175.

[11] Lu J, Huo W, Ma Y, Wang X, Yu J. Suppressive immune microenvironment and CART therapy for glioblastoma: future prospects and challenges. Cancer Lett. 2024; 600:217185.

[12] Cai Q, Cai W, Liu Y, et al. Advancing lymph node metastasis in head and neck squamous cell carcinoma: integrative mechanisms, emerging diagnostics, and translational therapies. Crit Rev Oncol Hematol. 2025; 215:104854.

[13] Hristozova T, Konschak R, Stromberger C, et al. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Ann Oncol. 2011; 22(8): 1878-1885.

[14] Barsch M, Salié H, Schlaak AE, et al. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. J Hepatol. 2022; 77(2): 397-409.

[15] Chu X, Tian Y, Lv C. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. Mol Cancer. 2024; 23(1): 150.

[16] Li Z, Xia Q, He Y, Li L, Yin P. MDSCs in bone metastasis: mechanisms and therapeutic potential. Cancer Lett. 2024; 592:216906.

[17] Zheng H, An M, Luo Y, et al. PDGFRα+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay. Cancer Cell. 2024; 42(4): 682-700.e12.

[18] Hamey FK, Lau WWY, Kucinski I, et al. Single-cell molecular profiling provides a high-resolution map of basophil and mast cell development. Allergy. 2021; 76(6): 1731-1742.

[19] Ruffin AT, Li H, Vujanovic L, Zandberg DP, Ferris RL, Bruno TC. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nat Rev Cancer. 2023; 23(3): 173-188.

[20] Kürten CHL, Kulkarni A, Cillo AR, et al. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021; 12(1): 7338.

[21] Cillo AR, Kürten CHL, Tabib T, et al. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity. 2020; 52(1): 183-199.e9.

[22] Cha J, Kim DH, Kim G, et al. Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes. J Immunother Cancer. 2024; 12(6):e008667.

[23] Bill R, Wirapati P, Messemaker M, et al. CXCL9:sPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science. 2023; 381(6657): 515-524.

[24] Puram SV, Mints M, Pal A, et al. Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma. Nat Genet. 2023; 55(4): 640-650.

[25] Choi J-H, Lee B-S, Jang JY, et al. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer. Nat Commun. 2023; 14(1): 1055.

[26] Jenkins BH, Tracy I, Rodrigues MFSD, et al. Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response. Mol Cancer. 2025; 24(1): 3.

[27] Wichmann G, Rosolowski M, Krohn K, et al. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int J Cancer. 2015; 137(12): 2846-2857.

[28] Lohavanichbutr P, Méndez E, Holsinger FC, et al. A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation. Clin Cancer Res. 2013; 19(5): 1197-1203.

[29] Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021; 2(3):100141.

[30] Haghverdi L, Buettner F, Theis FJ. Diffusion maps for high-dimensional single-cell analysis of differentiation data. Bioinformatics. 2015; 31(18): 2989-2998.

[31] Qiu X, Mao Q, Tang Y, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017; 14(10): 979-982.

[32] Cao J, Spielmann M, Qiu X, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019; 566(7745): 496-502.

[33] Street K, Risso D, Fletcher RB, et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics. 2018; 19(1): 477.

[34] Li Q. scTour: a deep learning architecture for robust inference and accurate prediction of cellular dynamics. Genome Biol. 2023; 24(1): 149.

[35] Gulati GS, Sikandar SS, Wesche DJ, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020; 367(6476): 405-411.

[36] Aibar S, González-Blas CB, Moerman T, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017; 14(11): 1083-1086.

[37] Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021; 12(1): 1088.

[38] Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016; 17(1): 218.

[39] Steen CB, Liu CL, Alizadeh AA, Newman AM. Profiling cell type abundance and expression in bulk tissues with CIBERSORTx. Methods Mol Biol. 2020; 2117: 135-157.

[40] Racle J, Gfeller D. EPIC: a tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol Biol. 2020; 2120: 233-248.

[41] Tay JK, Narasimhan B, Hastie T. Elastic Net Regularization Paths for All Generalized Linear Models. J Stat Softw. 2023; 106(1): 1-31.

[42] Breiman L. Random forests. Machine Learning. 2001; 45(1): 5-32.

[43] Schröder MS, Culhane AC, Quackenbush J, Haibe-Kains B. survcomp: an R/Bioconductor package for performance assessment and comparison of survival models. Bioinformatics. 2011; 27(22): 3206-3208.

[44] GraphPad Prism (Version 10.0.2). GraphPad Software, LLC; 2024. https://www.graphpad.com

[45] Zhao M, Schoenfeld JD, Egloff AM, et al. T cell dynamics with neoadjuvant immunotherapy in head and neck cancer. Nat Rev Clin Oncol. 2025; 22(2): 83-94.

[46] Kersten K, Hu KH, Combes AJ, et al. Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer. Cancer Cell. 2022; 40(6): 624-638.e9.

[47] Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022; 19(6): 402-421.

[48] Baessler A, Vignali DAA. T cell exhaustion. Annu Rev Immunol. 2024; 42: 179-206.

[49] Barsch M, Salié H, Schlaak AE, et al. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. J Hepatol. 2022; 77(2): 397-409.

[50] Wu JE, Manne S, Ngiow SF, et al. In vitro modeling of CD8+ T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40. Sci Immunol. 2023; 8(86):eade3369.

[51] Li Y, Zheng Y, Huang J, et al. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut. 2025; 74(3): 350-363.

[52] Ren YF, Ma Q, Zeng X, et al. Single-cell RNA sequencing reveals immune microenvironment niche transitions during the invasive and metastatic processes of ground-glass nodules and part-solid nodules in lung adenocarcinoma. Mol Cancer. 2024; 23(1): 263.

[53] Patterson MT, Firulyova MM, Xu Y, et al. TREM2 promotes foamy macrophage lipid uptake and survival in atherosclerosis. Nat Cardiovasc Res. 2023; 2(11): 1015-1031.

[54] Timperi E, Gueguen P, Molgora M, et al. Lipid-Associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Cancer Res. 2022; 82(18): 3291-3306.

[55] Lavin Y, Kobayashi S, Leader A, et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell. 2017; 169(4): 750-765.e17.

[56] Zhou L, Wang M, Guo H, et al. Integrated analysis highlights the immunosuppressive role of TREM2+ macrophages in hepatocellular carcinoma. Front Immunol. 2022; 13:848367.

[57] Molgora M, Liu YA, Colonna M, Cella M. TREM2: a new player in the tumor microenvironment. Semin Immunol. 2023; 67:101739.

[58] Zhang Y, Chen H, Mo H, et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell. 2021; 39(12): 1578-1593.e8.

[59] Sharma A, Seow JJW, Dutertre CA, et al. Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma. Cell. 2020; 183(2): 377-394.e21.

[60] Chow LQM. Head and neck cancer. N Engl J Med. 2020; 382(1): 60-72.

[61] Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020; 6(1): 92.

[62] Wen J, Wei Y, Jabbour SK, et al. Comprehensive analysis of prognostic value of lymph node staging classifications in patients with head and neck squamous cell carcinoma after cervical lymph node dissection. Eur J Surg Oncol. 2021; 47(7): 1710-1717.

[63] Jia X, Tian J, Fu Y, et al. Identification of AURKA as a biomarker associated with cuproptosis and ferroptosis in HNSCC. Int J Mol Sci. 2024; 25(8): 4372.

[64] Jiang X, Ke J, Jia L, et al. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. J Cancer Res Clin Oncol. 2023; 149(1): 203-218.

[65] Li K, Zhang C, Zhou R, et al. Single cell analysis unveils B cell-dominated immune subtypes in HNSCC for enhanced prognostic and therapeutic stratification. Int J Oral Sci. 2024; 16(1): 29.

[66] Wang Y, Gu W, Wen W, Zhang X. SERPINH1 is a potential prognostic biomarker and correlated with immune infiltration: a pan-cancer analysis. Front Genet. 2021; 12:756094.

[67] Zhang M, Li Q, Zhang W, Yang Y, Gu J, Dong Q. Identification and validation of genes associated with copper death in oral squamous cell carcinoma based on machine learning and weighted gene co-expression network analysis. J Stomatol Oral Maxillofac Surg. 2023; 124(6s):101561.

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.